Dr Olivier Laczka

Chief Scientific Officer

BSc, MSc, PhD

Olivier is a highly experienced leader in drug development, biopharmaceuticals, biotechnology and diagnostics. He serves as Chief Scientific Officer – Inflammation at Noxopharm Ltd, and as Chief Scientific Officer for Pharmorage Pty Ltd.

His skillset includes immunoassays, patents, scientific writing and grants, as well as people and project management. Olivier brings to Pharmorage diverse experience in generating both intellectual property and research funding, along with managing effective collaborations with commercial organisations, academic institutions, governments, and private entities at the international level.

Prior to joining Noxopharm, Olivier was a senior research scientist with 3M, PriME Biologics and AEGROS Innovations. He also has had international academic experience with UTS Sydney, Macquarie University, and the Institute of Microelectronics of Barcelona.

Olivier holds a PhD in Biotechnology from the Autonomous University of Barcelona, a Master of Applied Biotechnology and Microbiology from Ecole Supérieure d’Ingénieur de Luminy in Marseille, and a Bachelor degree in Biology and Environmental Sciences from the Institut Universitaire de Technology in Nantes.